References

Considerations in the development of circulating tumor cell technology for clinical use

10.1186/1479-5876-10-138 · 2012 · External reference

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

10.1158/1078-0432.ccr-04-0378 · 2004 · External reference

A new device for rapid isolation by size and characterization of rare circulating tumor cells

2011 · External reference

The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients

10.1097/jto.0b013e3181989565 · 2009 · External reference

High speed detection of circulating tumor cells

10.1016/j.bios.2005.12.024 · 2006 · External reference

Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer

10.1186/1471-2407-12-548 · 2012 · External reference

Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer

10.1373/clinchem.2010.143297 · 2010 · External reference

Prognostic and predictive roles of KRAS mutation in colorectal cancer

10.3390/ijms131012153 · 2012 · External reference

Molecular biomarker analyses using circulating tumor cells

10.1371/journal.pone.0012517 · 2010 · External reference

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells

10.1093/jnci/djn419 · 2009 · External reference

Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells

10.1126/scitranslmed.3005616 · 2013 · External reference

Changes in automated complete blood cell count and differential leukocyte count results induced by storage of blood at room temperature

10.5858/2002-126-0336-ciacbc · 2002 · External reference

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

10.1038/nature09460 · 2010 · External reference

Unresolved reference

2012 · External reference

The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer

10.5858/133.10.1600 · 2009 · External reference

Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line

10.1088/1478-3975/9/1/016002 · 2012 · External reference

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue

10.1002/ijc.27987 · 2013 · External reference

Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs

10.1016/j.canlet.2013.02.015 · 2013 · External reference

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

10.1186/1471-2407-11-422 · 2011 · External reference

Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns

10.1093/carcin/bgm176 · 2007 · External reference

EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer: implications for targeted therapy

2012 · External reference

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer

10.1373/clinchem.2012.188557 · 2013 · External reference